Jane Street’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-1,945
Closed -$245K – 12099
2025
Q4
$482K Sell
1,945
-6,831
-78% -$1.56M ﹤0.01% 7766
2025
Q3
$1.85M Buy
+8,776
New +$1.55M ﹤0.01% 5087
2025
Q2
– Sell
-8,543
Closed -$745K – 10097
2025
Q1
$752K Buy
8,543
+8,383
+5,239% +$775K ﹤0.01% 6100
2024
Q4
$11.6K Buy
+160
New +$11K ﹤0.01% 9169
2024
Q3
– Sell
-1,167
Closed -$84.1K – 9878
2024
Q2
$84.1K Sell
1,167
-2,862
-71% -$171K ﹤0.01% 8797
2024
Q1
$380K Buy
4,029
+1,256
+45% +$111K ﹤0.01% 7162
2023
Q4
$202K Buy
2,773
+2,599
+1,494% +$154K ﹤0.01% 8201
2023
Q3
$11.6K Sell
174
-3,973
-96% -$366K ﹤0.01% 8370
2023
Q2
$398K Sell
4,147
-11,992
-74% -$1.19M ﹤0.01% 6671
2023
Q1
$1.63M Buy
16,139
+14,958
+1,267% +$2.29M ﹤0.01% 4176
2022
Q4
$205K Sell
1,181
-630
-35% -$415K ﹤0.01% 7640
2022
Q3
$1.74M Buy
1,811
+615
+51% +$611K ﹤0.01% 4438
2022
Q2
$801K Buy
1,196
+800
+202% +$496K ﹤0.01% 5894
2022
Q1
$275K Buy
396
+46
+13% +$35.5K ﹤0.01% 8535
2021
Q4
$317K Sell
350
-250
-42% -$238K ﹤0.01% 8064
2021
Q3
$603K Buy
600
+347
+137% +$256K ﹤0.01% 6917
2021
Q2
$164K Buy
+253
New +$175K ﹤0.01% 8974
2021
Q1
– Sell
-406
Closed -$314K – 9284
2020
Q4
$314K Sell
406
-75
-16% -$59.1K ﹤0.01% 6336
2020
Q3
$477K Buy
+481
New +$510K ﹤0.01% 5223

Other funds holding GOSS

Jane Street's GOSS Position: Q1 2026 in Review

Jane Street sold out of Gossamer Bio (GOSS) in Q1 2026, closing a stake of 1,945 shares — an estimated $245K sold.

Jane Street first reported a position in GOSS in Q3 2020 and held it in 19 quarters. The position peaked at $1.85M in Q3 2025. 181 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • Jane Street reported no remaining Gossamer Bio position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,945 Gossamer Bio shares in Q1 2026, an estimated $245K.
  • Jane Street first reported a position in Gossamer Bio in Q3 2020 and held it in 19 quarters.
  • Jane Street's Gossamer Bio position peaked at $1.85M in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.